Meta-Analysis: Self as Dynamic Brain Coalitions in Psychedelic Neuroscience
A 2026 meta-analysis finds no single neural core for self-related processing, challenging prevailing models and informing psychedelic research on altered self-experience.
Meta-Analysis Finds No Single Neural Core for the Self
A November 2026 meta-analysis of 912 neuroimaging studies concludes that self-related processing in the brain does not arise from a single, consistent neural core but rather from shifting coalitions of distributed brain systems. The research, published in OpenAlex (W7234351643), systematically reviewed studies on various forms of self-experience, including autobiographical memory, body ownership, and interoception. The analysis found that while certain regions like the cortical midline and insula are frequently implicated, no single location was consistently significant across all forms of self-related processing. Instead, the patterns were distributed and varied depending on the specific aspect of self being studied.
Mechanism: Distributed, Dynamic Brain Networks Underpin Self-Experience
The meta-analysis supports a mechanism in which the experience of self arises from dynamic, graded contributions of multiple brain systems rather than from a static or localized neural substrate. By clustering study topics into ten distinct forms of self and mapping their associated brain activity, the authors demonstrated that each form recruits different, overlapping networks. These coalitions shift in configuration and strength depending on context and task, forming a continuous configuration space rather than discrete on/off regions. Notably, the study's predictive models showed that combinations of these distributed patterns better forecasted self-related brain activity in new data than any single region or binary network model.
This distributed, dynamic model aligns with recent computational neuroscience approaches and challenges the longstanding view that the self is anchored in specific midline or insular regions. For psychedelic neuroscience, this reframing is significant: it suggests that altered self-experience under psychedelics likely involves broad network reconfiguration rather than isolated regional effects.
Implications for Psychedelic Research and Neuroimaging
The findings have immediate implications for the design and interpretation of neuroimaging studies in psychedelic research. Trials investigating substances like psilocybin, LSD, and DMT often report changes in self-experience—such as ego dissolution—alongside alterations in specific brain regions. This meta-analysis cautions against attributing such effects to single neural loci and instead encourages researchers to consider distributed network dynamics and shifting coalitions when interpreting imaging results.
- Mechanistic Studies: Future mechanistic studies may need to employ network-level analyses and dynamic connectivity models, moving beyond region-of-interest approaches.
- Interpretation of Results: The absence of a neural core for the self complicates efforts to use imaging biomarkers as proxies for subjective self-experience in clinical trials.
- Trial Design: Researchers designing psychedelic trials may benefit from incorporating tasks and analyses that capture the fluid, context-dependent nature of self-related processing.
While the study does not directly impact regulatory or legal frameworks, it provides a more nuanced scientific foundation for interpreting the neural effects of psychedelics and may inform future guidance from agencies such as the U.S. Food and Drug Administration (FDA) regarding neuroimaging endpoints.
Risks, Unknowns, and Limitations
The distributed model of self-related processing introduces new complexities and uncertainties for both basic neuroscience and clinical translation. The lack of a single neural core means that interventions—pharmacological or otherwise—may have heterogeneous and unpredictable effects on self-experience, depending on individual brain network configurations and contextual factors. This complicates efforts to develop targeted therapies or predict therapeutic outcomes based on imaging data alone.
Another limitation is that meta-analyses rely on the quality and diversity of included studies. While the reviewed sample is large, it may still underrepresent certain populations or experimental paradigms, and the clustering of study topics is subject to interpretive bias. Finally, the findings highlight a broader challenge in neuroscience: the need for analytic tools capable of capturing dynamic, high-dimensional brain states, which remain underdeveloped in many clinical trial settings.
Looking Forward: New Directions for Psychedelic Neuroscience
The 2026 meta-analysis marks a conceptual shift in how researchers understand the neural basis of the self, with direct relevance for the psychedelic field. As clinical trials increasingly incorporate advanced neuroimaging and computational methods, this distributed, dynamic model will likely shape both mechanistic hypotheses and analytic strategies. For funders and institutions, the findings underscore the value of supporting research that integrates network neuroscience, computational modeling, and subjective experience. A non-obvious implication is that future regulatory science may need to adapt, recognizing that reliable biomarkers for self-related change may require multidimensional, individualized network signatures rather than universal regional markers.
How we research: This article was written and reviewed by Dr. Alex Morgan, PhD (Neuroscience), on 2026-11-20. Primary source: OpenAlex W7234351643.
Get tomorrow's briefing in your inbox
Policy, research, and regulatory signal — delivered on our publish cadence.